Home › Weight Control › North Carolina › Durham
Weight Control clinical trials in Durham, NC
4 studies for Weight Control are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
Recruiting
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecruitingPhase 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 mi away
Planning Grant for TOPS for Breast Cancer Survivors
Recruiting
- Duke University, Durham
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
RecruitingPhase 2
- Duke University Medical Center, Durham
About Weight Control
About two thirds of adults in the U.S. are overweight or obese. A weight control strategy can help you keep a healthy weight.
More about Weight Control on MedlinePlus
Weight Control trials in other cities
- New York City, NY11 studies
- Aurora, CO7 studies
- Kansas City, KS5 studies
- Chicago, IL5 studies
- Baltimore, MD5 studies
- Washington, DC5 studies
- Dallas, TX4 studies
- Los Angeles, CA4 studies
- Edison, NJ4 studies
- Birmingham, AL4 studies
- Boston, MA3 studies
- Baton Rouge, LA3 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)59 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Metastatic Cancer33 studies
- Acute Myeloid Leukemia33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Chronic Lymphocytic Leukemia27 studies
- Ovarian Cancer27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.